Sign in and upgrade to a paid plan to export financials as CSV.

Natural Capsules Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: NATCAPSUQ BSE: 524654
₹165.80
Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #126 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Natural Capsules Limited (this stock) 173 13.5 -10.5% -39.1% — 45 95 31

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹231 Cr
EV / EBITDA
7.4x
EV / Sales
1.34x
Market cap / Sales
1.00x
Earnings yield
7.41%

Quarterly Financials

↓ Negative
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 45 Cr, down 1.3% YoY.

↑ Positive
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 4 Cr, up 60.0% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 43 6 4 ₹3.8900
March 31, 2026 51 7 6 ₹5.3300
Dec. 31, 2025 34 0 0 ₹0.3500
Sept. 30, 2025 45 4 3 ₹2.7200
June 30, 2025 44 3 3 ₹2.4400
March 31, 2025 44 3 3 ₹2.1700
Dec. 31, 2024 43 2 2 ₹1.6500
Sept. 30, 2024 41 2 1 ₹0.9000
June 30, 2024 39 2 1 ₹1.5600
March 31, 2024 40 2 2 ₹2.0900
Dec. 31, 2023 38 2 2 ₹1.8200
Sept. 30, 2023 38 3 2 ₹2.1100
June 30, 2023 38 3 2 ₹2.6400

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Total income (before exceptional items)45533646464645424041393838
Operating revenue43513445444443413940383838
Other income2222221111111
Operating expenses36423239393939363436333232
Operating profit7925555555556
Operating profit margin16.0%17.4%5.6%12.2%11.6%11.4%10.6%12.0%12.1%11.2%12.9%14.0%16.1%
Depreciation2222222222222
Interest1111121211111
Exceptional items, gain / (loss)—————————————
Profit before tax6704332222233
Tax2201111101111
Net profit460—3—2112222
EPS3.895.330.352.722.442.171.650.901.562.091.822.112.64
Net profit (TTM)——————667891316
EPS (TTM)12.2910.847.688.987.166.286.206.377.588.66———

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year endedRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)
March 31, 2026 174 15 11
March 31, 2025 168 9 7

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 19Mar 18Mar 17
Total income (before exceptional items) 1.4% 17.7% 181†172†157†174†136†80†61†59†54†
Operating revenue 0.2% 16.9% 174168154†173†135†80†60†58†54†
Other income — — 8†4†3†1†1†1†1†1†1†
Operating expenses — — 152†149†133†137†110†—55†—48†
Operating profit -15.6% — 21†19†21†35†26†—5†—5†
Operating profit margin — — 12.3%†11.5%†13.5%†20.5%†18.9%†—7.9%†—10.2%†
Depreciation — — 8†8†9†7†5†—3†—4†
Interest — — 6†6†5†4†2†0†0†0†1†
Exceptional items, gain / (loss) — — 0†0†0†0†0†2†-0†0†-1†
Profit before tax -16.4% 10.5% 15910†26†19†9†2†2†0†
Tax — — 4†3†3†7†5†2†0†1†-0†
Net profit -16.4% 10.2% 1178†19†14†7†2†1†1†
EPS — 8.9% 10.84†6.28†8.66†—20.45†7.07†———

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 19Mar 18Mar 17
Operating margin12.3%†11.5%†13.5%†20.5%†18.9%†—7.9%†—10.2%†
EBIT margin12.0%†9.1%†10.0%†17.0%†15.8%†12.0%†4.1%†3.2%†1.7%†
PBT margin8.7%5.5%6.8%†14.9%†14.4%†11.5%†3.5%†2.9%†0.6%†
Net margin6.5%4.0%5.1%†11.1%†10.3%†8.7%†3.3%†1.9%†1.2%†
Interest coverage3.62x†2.57x†3.11x†8.23x†10.92x†25.05x†6.62x†9.00x†1.54x†
Dividend payout—————————
Earnings retention—————————
Current ratio1.01x1.28x———————
Quick ratio0.79x1.00x———————
Debt to equity0.32x0.33x———————
Return on equity6.2%4.0%———————
Return on assets3.8%2.5%———————
Return on capital employed10.1%†7.9%†———————
Asset turnover0.59x0.63x———————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 36 -34 -3 10 26
March 31, 2025 18 -34 15 2 16

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 296 180 169 39 19 91 91 0 87 20
March 31, 2025 268 166 156 35 20 97 75 1 87 21

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.